Transfection with a cripto anti-sense plasmid suppresses endogenous cripto expression and inhibits transformation in a human embryonal carcinoma cell line

International Journal of Cancer

Volumn 66, Issue 4, 1996, Pages 538-543

  Baldassarre, Gustavo ^a   Bianco, Caterina ^a   Tortora, Giampaolo ^a   Ruggiero, Angela ^a   Moasser, Mark ^b   Dmitrovsky, Ethan ^b   Bianco, A Raffaele ^a   Ciardiello, Fortunato ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CRIPTO; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYONAL CARCINOMA; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL;

BASE SEQUENCE; CARCINOMA, EMBRYONAL; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DNA PRIMERS; EPIDERMAL GROWTH FACTOR; GROWTH SUBSTANCES; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PLASMIDS; RNA, ANTISENSE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029890271     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960516)66:4<538::AID-IJC19>3.0.CO;2-3     Document Type: Article

References (26)

1. ANDREWS, P.W., Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol., 103, 285-293 (1984).
2. ANDREWS, P.W., NUDELMAN, E., HAKOMORI, S. and FENDERSON, B.A., Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxy-uridine (BUdR). Differentiation, 43, 131-138 (1990).
3. BASELGA, J., MAERZ, W.J., MOY, D., MILLER, W.H., CASTRO, L., REUTER, V.E., YAO, T.J., MASUI, H. and DMITROVSKY, E., Overexpression of transforming growth factor α antagonizes the antitumorigenic but not the differentiation actions of retinoic acid in a human embryonal carcinoma cell. Oncogene, 8, 3257-3263 (1993).
4. BRANDT, R., NORMANNO, N., GULLICK, W.I., LIN, J.-H., HARKINS, R., SCHNEIDER, D., WALLACE-JONES, B., CIARDIELLO, F., PERSICO, M.G., ARMENANTE, F., KIM, N. and SALOMON, D.S., Identification and biological characterization of epidermal growth factor-related protein: CRIPTO-1. J. biol. Chem., 269, 17320-17328 (1994).
5. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol chloroform extraction. Anal Biochem., 162, 156-159 (1987).
6. CIARDIELLO, F., BIANCO, C., NORMANNO, N., BALDASSARRE, G., PEPE, S., TORTORA, G., BIANCO, A.R. and SALOMON, D.S., Infection with a transforming growth factor α anti-sense retroviral expression vector reduces the in vitro growth and transformation of a human colon cancer cell line. Int. J. Cancer, 54, 952-958 (1993).
7. CIARDIELLO, F., DONO, R., KIM, N., PERSICO, M.G. and SALOMON, D.S., Expression of cripto, a novel gene of the epidermal growth factor family, leads to in vitro transformation of a normal mouse mammary epithelial cell line. Cancer Res., 51, 1051-1054 (1991a).
8. CIARDIELLO, F., KIM, N., SAEKI, T., DONO, R., PERSICO, M.G., PLOWMAN, G.D., GARRIGUES, J., REDKE, S., TODARO, G.J. and SALOMON, D.S., Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc. nat. Acad. Sci. (Wash.), 88, 7792-7796 (1991b).
9. CIARDIELLO, F., TORTORA, G., BIANCO, C., SELVAM, M.P., BASOLO, F., FONTANINI, G., PACIFICO, F., NORMANNO, N., BRANDT, R., PERSICO, M.G., SALOMON, D.S. and BIANCO, A.R., Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides. Oncogene, 9, 291-298 (1994).
10. CICCODICOLA, A., DONO, R., OBICI, S., SIMEONE, A., ZOLLO, M. and PERSICO, M.G., Molecular characterization of a gene of the "EGF family" expressed in undifferentiated human NTERA2 embryonal carcinoma cells. EMBO J., 8, 1987-1991 (1989).
11. DMITROVSKY, E., MOY, D., MILLER, W.H., LI, A. and MASUI, H., Retinoic acid causes a decline in TGF- α expression, cloning efficiency, and tumorigenicity in a human embryonal cancer cell line. Oncogene Res., 5, 233-239 (1990).
12. FENDERSON, B.A., ANDREWS, P.W., NUDELMAN, E., CLAUSEN, H. and HAKOMORI, S., Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA2-derived human embryonal carcinoma cells. Dev. Biol., 122, 21-34 (1987).
13. FRIESS, H., YAMANAKA, Y., BUCHLER, M., KOBRIN, M.S., TAHARA, E. and KORC, M., CRIPTO, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis. Int. J. Cancer, 56, 668-674 (1994).
14. KENNEY, N., JOHNSON, G., SELVAM, M.P., KIM, N., QI, C-F., SAEKI, T., BRANDT, R., WALLACE-JONES, B., CIARDIELLO, F., SHOYAB, M., PLOWMAN, G., DAY, A., SALOMON, D.S. and NORMANNO, N., Transforming growth factor α (TGFα) and amphiregulin (AR) as autocrine growth factors in nontransformed, immortalized 184A1N4 human mammary epithelial cells. Mol. cell. Differ., 1, 163-184 (1993a).
15. KENNEY, N., SAEKI, T., GOTTARDIS, M., KIM, N., GARCIA-MORALES, P., MARTIN, M.-B., NORMANNO, N., CIARDIELLO, F., DAY, A., CUTLER, M.L. and SALOMON, D.S., Expression of transforming growth factor α antisense mRNA inhibits the estrogen-induced production of TGFα and estrogen-induced proliferation of estrogen-responsive human breast cancer cells. J. cell. Physiol., 156, 497-524 (1993b).
16. LEE, D.C., FENTON, S.E., BERKOWITZ, E.A. and HISSONG, A., Transforming growth factor α: expression, regulation, and biological activities. Pharmacol. Rev., 47, 51-85 (1995).
17. MILLER, W.H., MOY, D., LI, A., GRIPPO, J.F. and DMITROVSKY, E., Retinoic acid induces down-regulation of multiple growth factors and proto-oncogenes in a human embryonal cancer cell line. Oncogene, 5, 511-517 (1990).
18. MOASSER, M., DE BLASIO, A. and DMITROVSKY, E., Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor γ in human teratocarcinomas. Oncogene, 9, 833-840 (1994).
19. NECKERS, L., WHITESELL, L., ROSOLEN, A. and GESELOWITZ, D.A., Antisense inhibition of oncogene expression. Crit. Rev. Oncogenesis, 3, 175-231 (1992).
20. NORMANNO, N., BIANCO, C., DAMIANO, V., DE ANGELIS, E., SELVAM, M.P., GRASSI, M., MAGLIULO, G., TORTORA, G., BIANCO, A.R., MENDELSOHN, J., SALOMON, D.S. and CIARDIELLO, F., Growth inhibition of human colon carcinoma cells by combinations of anti-EGF-related growth factors antisense oligonucleotides. Clin. Cancer Res., 2, (1996) (In press).
21. NORMANNO, N., SELVAM, M.P., QI, C-F., SAEKI, T., JOHNSON, G.R., KIM, N., CIARDIELLO, F., SHOYAB, M., PLOWMAN, G.D., TODARTO, G. and SALOMON, D.S., Amphiregulin as an autocrine growth factor for c-Ha-ras and c-erbB-2 transformed human mammary epithelial cells. Proc. nat. Acad. Sci. (Wash.), 91, 2790-2794 (1994).
22. QI, C-F., LISCIA, D.S., NORMANNO, N., MERLO, G., JOHNSON, G.R., GULLICK, W.J., CIARDIELLO, F., SAEKI, T., BRANDT, R., KIM, N., KENNEY, N. and SALOMON, D.S., Expression of transforming growth factor α, amphiregulin and cripto-1 in human breast carcinomas. Brit. J. Cancer, 69, 903-910 (1994).
23. SAEKI, T., SALOMON, D.S., NORMANNO, N., JOHNSON, G.R., GULLICK, W.J., MANDAI, K., MORIWAKI, S., TAKASHIMA, S., KUNIYASU, M., TAHARA, E., KAWAMI, H., NISHIYAMA, M. and TOGE, T., Immunohistochemical detection of cripto-1, amphiregulin and transforming growth factor alpha in human gastric carcinomas and intestinal metaplasias. Int. J. Oncol., 5, 215-223 (1994).
24. SAEKI, T., STROMBERG, K., QI, C-F., GULLICK, W.J., TAHARA, E., NORMANNO, N., CIARDIELLO, F., KENNEY, N., JOHNSON, G.R. and SALOMON, D.S., Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors. Cancer Res., 52, 3467-3473 (1992).
25. SALOMON, D.S., BRANDT, R., CIARDIELLO, F. and NORMANNO, N., Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Hemat. Oncol., 19, 183-232 (1995).
26. SHEVINSKY, L.H., KNOWLES, B.B., DAMJANOV, I. and SOLTER, D., Monoclonal antibody to murine embryos defines a stage-specific embryonic antigen expressed on mouse embryos and human embryonal carcinomas cells. Nature (Lond.), 346, 763-766 (1982).